Genome Center for Alzheimer's Disease (GCAD) — GERARD DAVID SCHELLENBERG (UNIVERSITY OF PENNSYLVANIA)
Overall Project Summary Alzheimer’s disease (AD) affects 5.8 million people in the United States, and is an immense burden on patients, caregivers and on the economy. No disease-modifying treatments o
| Project title | Genome Center for Alzheimer's Disease (GCAD) |
|---|---|
| Project number | 5U54AG052427-09 |
| PI name | GERARD DAVID SCHELLENBERG |
| Institution | UNIVERSITY OF PENNSYLVANIA |
| Funding mechanism | U54 |
| Agency | NIA |
| Award amount | $3.95M |
| Fiscal year | 2024 |
| Project start | 2016-04-15T00:00:00 |
| Project end | 2026-03-31T00:00:00 |
| Abstract | Overall Project Summary Alzheimer’s disease (AD) affects 5.8 million people in the United States, and is an immense burden on patients, caregivers and on the economy. No disease-modifying treatments o |
| Key terms | <AD dementia><AD related dementia><ADRD><AI system><ATAC sequencing><ATAC-seq><ATACseq><Abbreviation |
$799/mo
Try GrantRadar →